Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

13 collaborators·55 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Seattle Children's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lawrence Ginsberg, MD

Red Oaks Psychiatry Associates, PA

Moderately Similar
4 trials

Shared therapeutic areas:

Fragile X SyndromeAutism Spectrum Disorder

Worked with same sponsors:

Seaside Therapeutics, Inc.
Collaborated on 4 trials
Similarity Score36%

Jeremy Veenstra-VanderWeele, MD

Vanderbilt Kennedy Center

Moderately Similar
4 trials

Shared therapeutic areas:

Fragile X SyndromeAutism Spectrum Disorder

Worked with same sponsors:

Seaside Therapeutics, Inc.
Collaborated on 4 trials
Similarity Score36%

James McCracken, MD

University of California, Los Angeles

Moderately Similar
8 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome

Worked with same sponsors:

Seaside Therapeutics, Inc.
Collaborated on 4 trials
Similarity Score36%

Linmarie Sikich, MD

University of North Carolina Neurosciences Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Fragile X SyndromeAutism Spectrum Disorder

Worked with same sponsors:

Seaside Therapeutics, Inc.
Collaborated on 4 trials
Similarity Score36%

Raun Melmed, MD

Southwest Autism Research & Resource Center

Moderately Similar
4 trials

Shared therapeutic areas:

Fragile X SyndromeAutism Spectrum Disorder

Worked with same sponsors:

Seaside Therapeutics, Inc.
Collaborated on 4 trials
Similarity Score36%

Craig Erikson, MD

Riley Hospital for Children

Moderately Similar
4 trials

Shared therapeutic areas:

Fragile X SyndromeAutism Spectrum Disorder

Worked with same sponsors:

Seaside Therapeutics, Inc.
Collaborated on 4 trials
Similarity Score36%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Moderately Similar
35 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome
Similarity Score30%

Forbes D Porter, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Moderately Similar
15 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome
Similarity Score30%

Alexander Kolevzon, MD

Icahn School of Medicine at Mount Sinai

Moderately Similar
13 trials

Shared therapeutic areas:

Autism Spectrum DisorderFragile X Syndrome
Similarity Score30%

Craig Erickson, MD

Children's Hospital Medical Center, Cincinnati

Moderately Similar
5 trials

Shared therapeutic areas:

Fragile X SyndromeAutism Spectrum Disorder
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00788073Phase 2PrincipalInvestigator

Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome

Fragile X Syndrome
Completed
NCT00823368PrincipalInvestigator

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

Fragile X Syndrome
Completed
NCT00846547Phase 2PrincipalInvestigator

Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders

Autism Spectrum Disorders
Completed
NCT00892580PrincipalInvestigator

Biomarker and DNA Collection in Subjects Participating in Protocol 22003

Fragile X Syndrome
Completed

All 4 trials loaded